QT prolongation is associated with increased mortality in end stage liver disease

@inproceedings{Kim2017QTPI,
  title={QT prolongation is associated with increased mortality in end stage liver disease},
  author={Sun Moon Kim and Bennet George and Diego Alcivar-Franco and Charles Leo Campbell and Richard J. Charnigo and Brian P. Delisle and Jonathan C. Hundley and Yousef H Darrat and Gustavo Ruiz Morales and Samy-Claude Elayi and Alison L. Bailey},
  booktitle={World journal of cardiology},
  year={2017}
}
AIM To determine the prevalence of QT prolongation in a large series of end stage liver disease (ESLD) patients and its association to clinical variables and mortality. METHODS The QT interval was measured and corrected for heart rate for each patient, with a prolonged QT cutoff defined as QT > 450 ms for males and QT > 470 ms for females. Multiple clinical variables were evaluated including sex, age, serum sodium, international normalized ratio, creatinine, total bilirubin, beta-blocker use… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 49 REFERENCES

Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis.

  • Liver international : official journal of the International Association for the Study of the Liver
  • 2012

QT dispersion in cirrhotic patients before and after liver transplantation

JH Henriksen, F Bendtsen, EF Hansen, S. Møller
  • Arch Iran Med
  • 2012